MUMBAI, India, Jan. 23 -- Intellectual Property India has published a patent application (202521124988 A) filed by Dr. D. Y. Patil Institute Of Pharmaceutical Sciences And Research; School Of Pharmacy And Research; and Dr. Vrushali Neve, Pune, Maharashtra, on Dec. 11, 2025, for 'computational and in-vitro assessment of the anti-cancer activity of moringa oleifera in colon cancer.'
Inventor(s) include Dr. Vrushali Neve; Mr. Pawan N. Karwa; and Mr. Abhijit Kamble.
The application for the patent was published on Jan. 23, under issue no. 04/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to the identification and evaluation of bioactive compounds from Moringa oleifera for their therapeutic potential against colon cancer through an integrated in-silico and in-vitro approach. Selected phytochemicals were screened using molecular docking, drug-likeness filters, and drug disease pathway to predict their interaction with colon cancer-associated protein targets. Compounds demonstrating favorable binding affinity and pharmacokinetic characteristics were subsequently evaluated through in-vitro cytotoxicity assays on colon cancer cell lines. The combined computational and experimental findings confirm that specific Moringa oleifera constituents possess significant, target-specific anti-cancer activity, indicating their potential utility in the development of cost-effective, plant-derived therapeutics for colon cancer management."
Disclaimer: Curated by HT Syndication.
